Analysis of trace elements (Arsenic, Cadmium, Lead, and Mercury) in over-the-counter medicines from the United Kingdom, the Kingdom of Saudi Arabia, and India

Elemental impurities (EIs) in pharmaceuticals have become the subject of widespread interest. This is due to the implementation of new regulations by the United States Pharmacopoeia (USP <232>/<233>) and the International Council for Harmonisation (ICH Q3D) in 2018. These regulations mandate the monitoring of a wide range of elements, often present at low concentrations in pharmaceuticals. The aim of this study was to determine the concentrations of EIs (As, Cd, Pb, and Hg) in over-the-counter (OTC) medicines and evaluate possible human exposure to these trace elements, as well as to calculate and compare daily exposure values with the available USP <232>/<233> regulations. To do so, 38 common OTC medicines (paracetamol, cough, and ibuprofen/profen syrups) were collected from the United Kingdom (UK), the Kingdom of Saudi Arabia (KSA), and India. The samples were acid digested and then analysed using Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Weighted calibration curves and USP <232>/<233> ICH Q3D validation guidelines, including standard additions methodology, were used for analytical validation. The mean concentration of As, Cd, Pb, and Hg in OTC medicines were 4.73, 1.71, 15.40, and 2.03 µg/L, respectively. The results revealed acceptable levels of As, Cd, and Hg, but the samples had a relatively high amount of Pb compared to other trace elements in various medicine types from all countries. The data obtained from this study demonstrate that commonplace non-compliance with recommended daily dosages could readily result in exposures to Pb, reaching up to 50% of the Permitted Daily Exposure (PDE) limits for Pb in pharmaceutical products as defined by USP<232> (5 μg/day). When supplemented by exposures from other sources, this level of exposure has the potential to cause adverse health effects, particularly in young children. The use of a weighted calibration curve was shown to improve the accuracy of the analysis, particularly for concentrations close to method detection limits (DLs), whilst standard additions methodology was found to reduce matrix effects.

Authors

Institutions

Publication Details

Journal
Arabian Journal of Chemistry
Published
2025-07-26
DOI
https://doi.org/10.25259/ajc_318_2024
Primary Topic
Heavy Metals in Plants
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of trace elements (Arsenic, Cadmium, Lead, and Mercury) in over-the-counter medicines from the United Kingdom, the Kingdom of Saudi Arabia, and India

Andrew R. Pitt, Abby Ragazzon-Smith, David A. Polya, Ilya Strashnov et al.
Arabian Journal of Chemistry
Heavy Metals in Plants
article

Analysis of trace elements (Arsenic, Cadmium, Lead, and Mercury) in over-the-counter medicines from the United Kingdom, the Kingdom of Saudi Arabia, and India

Andrew R. Pitt, Abby Ragazzon-Smith, David A. Polya, Ilya Strashnov, May M. Alrashdi
article en

Abstract

Elemental impurities (EIs) in pharmaceuticals have become the subject of widespread interest. This is due to the implementation of new regulations by the United States Pharmacopoeia (USP <232>/<233>) and the International Council for Harmonisation (ICH Q3D) in 2018. These regulations mandate the monitoring of a wide range of elements, often present at low concentrations in pharmaceuticals. The aim of this study was to determine the concentrations of EIs (As, Cd, Pb, and Hg) in over-the-counter (OTC) medicines and evaluate possible human exposure to these trace elements, as well as to calculate and compare daily exposure values with the available USP <232>/<233> regulations. To do so, 38 common OTC medicines (paracetamol, cough, and ibuprofen/profen syrups) were collected from the United Kingdom (UK), the Kingdom of Saudi Arabia (KSA), and India. The samples were acid digested and then analysed using Inductively Coupled Plasma-Mass Spectrometry (ICP-MS). Weighted calibration curves and USP <232>/<233> ICH Q3D validation guidelines, including standard additions methodology, were used for analytical validation. The mean concentration of As, Cd, Pb, and Hg in OTC medicines were 4.73, 1.71, 15.40, and 2.03 µg/L, respectively. The results revealed acceptable levels of As, Cd, and Hg, but the samples had a relatively high amount of Pb compared to other trace elements in various medicine types from all countries. The data obtained from this study demonstrate that commonplace non-compliance with recommended daily dosages could readily result in exposures to Pb, reaching up to 50% of the Permitted Daily Exposure (PDE) limits for Pb in pharmaceutical products as defined by USP<232> (5 μg/day). When supplemented by exposures from other sources, this level of exposure has the potential to cause adverse health effects, particularly in young children. The use of a weighted calibration curve was shown to improve the accuracy of the analysis, particularly for concentrations close to method detection limits (DLs), whilst standard additions methodology was found to reduce matrix effects.

Arabian Journal of ChemistryVol. 18
Jouf University (SA), University of Manchester (GB)
Openalex Percentile: Top 80%
Heavy Metals in Plants
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.